0001354457-17-000018.txt : 20170125
0001354457-17-000018.hdr.sgml : 20170125
20170125101322
ACCESSION NUMBER: 0001354457-17-000018
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20170125
DATE AS OF CHANGE: 20170125
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ESCALON MEDICAL CORP
CENTRAL INDEX KEY: 0000862668
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330272839
STATE OF INCORPORATION: PA
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20127
BUSINESS ADDRESS:
STREET 1: 435 DEVON PARK ROAD
STREET 2: BUILDING 100
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 6106886830
MAIL ADDRESS:
STREET 1: 435 DEVON PARK ROAD
STREET 2: BUILDING 100
CITY: WAYNE
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: INTELLIGENT SURGICAL LASERS INC
DATE OF NAME CHANGE: 19930328
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0000862668
ESCALON MEDICAL CORP
000-20127
435 Devon Park Road, Building 100
Wayne
PA
PENNSYLVANIA
19087
610 688-6830
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2017-01-25
EX-99.25
2
esmcdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
January 25, 2017, Escalon Medical Corp. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Escalon Medical Corp.
(the Company), effective at the opening of the trading
session on February 6, 2017. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(1).
The Company was notified of the Staffs determination on
August 18, 2016. The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
October 19, 2016, granting the Company continued listing
pursuant to an exception that included several milestones
that the Company was required to meet, towards the toal
of regaining compliance with Listing Rule 5550(b)(1)
and 5550(a)(2). However, the Company was
unable to meet the exception milestones as required.
On November 16, 2016, the Panel issued a final delisting
determination and notified the Company that trading in the Companys
securities would be suspended on November 18, 2016.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on January 3, 2017.